He has expertise in competition, data protection, pharmaceutical, sanctions and export control law. He also regularly advises on the application of the National Security and Investment Act to corporate transactions, including obtaining clearances.
Jeremy’s focus is on providing straightforward, practical advice on complex issues, enabling clients to take informed risk-based decisions. As a regulatory lawyer, he is always keen to find solutions to issues that allow clients to progress their plans whilst minimising risk.
Jeremy co-authored the UK chapters of the 2024 Global Competition Review Guide to Life Sciences and the 2023 Global Legal Insights guide to Merger Control.
He has previously co-authored a study for the European Parliament on the impacts on the EU-Singapore Free Trade Agreement, and has provided training to the UK Department for International Trade on EU trade policy.
Clients increasingly have to consider regulatory risk when executing their plans. We are here to enable those plans and protect them from regulatory interference.